Skinbiotherapeutics Share Discussion Threads

[bdog51] 16/8/2018 13:39

when you take account of SOH clarification, there is nowt negative in that RNS, only positives. Some folk are playing games on here today, trying to move the share price down!

[montynj] 16/8/2018 13:38

I agree raftboy there's a lot of disinformation being posted on this thread today all of them are just the usual derampers. you've got the reply from soh regarding the rns and it seems very clear to me nothing wrong whatsoever

[mshilos] 16/8/2018 13:37

Watching my stock for this fall is not a happy experience ...why such a terribly worded RNS !?!?..the share price will go hack to under 20p IMHO.

[rayrac] 16/8/2018 13:35

Braver than most!

[scottishfield] 16/8/2018 13:31

A lot of nonsense on here today rafboy imo. I agree with you. Added.

[rafboy] 16/8/2018 13:27

The content of the RNS has been clarified with the company and SOH. It’s up to you what you do but I added a few today.

[judijudi] 16/8/2018 13:24

And how much is UKOG earning exactly?
Whats coming into the bottom line there?

[rayrac] 16/8/2018 13:19

Only if the ‘trials’ get going. But I think this is another opti, ie, nothing hitting the bottom line for years...if ever.

[mshilos] 16/8/2018 13:18

I agree Judi a terrible RNS and is likely to cause the share price to fall even more than it has already over the coming weeks.

[mshilos] 16/8/2018 13:16

I agree with you Matt and if the trials do not start in SEPT, as expected, due to this RNS set back, then a new RNS need to be issued to confirm the delay and so the share price will drop below 20p imminently and even lower, in a week or so , possibly back to 16p or lower IMHO.

[judijudi] 16/8/2018 13:15

This is the price you pay for arguably vague and arguably poorly worded RNS's
imho

[matt123d] 16/8/2018 13:11

If there is negative news then obviously supply will come to market and lower prices will be required to search for the demand. The levels which showed resistance on the way up will be potential areas of demand if prices do go lower.

[mshilos] 16/8/2018 13:06

John in reply : I stand by my opinion that the clinical trial will now have to be delayed and there will need to be an RNS to confirm this once they know when it will take place. The share price will fall to the initial April 2017 price or lower until we have trial results. This is still in its infancy and far far away from a profit generating business but the potential is huge hence the recent share price price rise based on sentiment and potential alone. This RNS is not good news...it will drop more ...IMO. DYOR.

[matt123d] 16/8/2018 13:05

It doesn't have to necessarily fall, just needs to consolidate through time or price or both.

[mshilos] 16/8/2018 12:56

Well I hope it does not fall to those levels !! It closed at 16p on day 1...then declined gor months.

[manc10] 16/8/2018 12:53

the share price launched at 9 p

[mshilos] 16/8/2018 12:46

I agree Matt...SP will fall as a result of what you say.

[mshilos] 16/8/2018 12:44

I agree 100 %. No trials next month..RNS to confirm. share price will drop below 19p doon ..even lower in weeks..back to 16p or lower IMHO.

[matt123d] 16/8/2018 12:43

The problem is the fall from the recent high without a quick bounce back from the 22/23p level has picked up investors now in losing positions. Either a large amount of fresh demand comes in or it goes lower to shake the losers out and meet the demand at a lower level, both of which take time.

[mshilos] 16/8/2018 12:42

I was referring to the 16 p April 7th 2017 price at launch.

[jamjason] 16/8/2018 12:40

If the trial was going ahead as planned next month, I doubt Andrew McBain and Manc University would have sold recently. That is my opinion.

[manc10] 16/8/2018 12:40

mshilos the ipo price was 9p

[mshilos] 16/8/2018 12:37

Opinions matter....why else are you on here ? share price has to fall until we have positive trial results...16 p or close to. Watch the drop over the coming weeks.DYOR.

[2350220] 16/8/2018 12:27

Mshilos, yet another expert who has suddenly got a profile a couple of weeks ago, offering such amazing insight.
Filtered.
John